TET2 c.4044+1G>A

Variant ID: 4-106183006-G-A

NM_001127208.2(TET2):c.4044+1G>A

This variant was identified in 5 publications

View GRCh38 version.




Publications:


A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study.

The Lancet. Haematology
,
Publication Date: 2022-11-24

Variant appearance in text: TET2: 4044+1G>A
PubMed Link: 36436542
Variant Present in the following documents:
  • mmc2.xlsx, sheet 1
View BVdb publication page



Serial Analysis and Comparison of Mutation Profiles in Decitabine-treated Myeloid Sarcoma and Subsequent Acute Myeloid Leukemia Using Next-Generation Sequencing.

Annals Of Laboratory Medicine
Park, Hee Sue HS; Son, Seung Myoung SM; Kwon, Jihyun J
Publication Date: 2022-09-01

Variant appearance in text: TET2: 4044+1G>A
PubMed Link: 35470279
Variant Present in the following documents:
  • Main text
  • alm-42-5-602.pdf
View BVdb publication page



Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.

Leukemia
Dawoud, Ahmed A Z AAZ; Gilbert, Rodney D RD; Tapper, William J WJ; Cross, Nicholas C P NCP
Publication Date: 2022-02

Variant appearance in text: TET2: 4044+1G>A
PubMed Link: 34413458
Variant Present in the following documents:
  • 41375_2021_1382_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.

Nature Communications
Nagata, Yasunobu Y; Makishima, Hideki H; Kerr, Cassandra M CM; Przychodzen, Bartlomiej P BP; Aly, Mai M; Goyal, Abhinav A; Awada, Hassan H; Asad, Mohammad Fahad MF; Kuzmanovic, Teodora T; Suzuki, Hiromichi H; Yoshizato, Tetsuichi T; Yoshida, Kenichi K; Chiba, Kenichi K; Tanaka, Hiroko H; Shiraishi, Yuichi Y; Miyano, Satoru S; Mukherjee, Sudipto S; LaFramboise, Thomas T; Nazha, Aziz A; Sekeres, Mikkael A MA; Radivoyevitch, Tomas T; Haferlach, Torsten T; Ogawa, Seishi S; Maciejewski, Jaroslaw P JP
Publication Date: 2019-11-26

Variant appearance in text: TET2: 4044+1G>A
PubMed Link: 31772163
Variant Present in the following documents:
  • 41467_2019_13001_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.

Oncogene
Kouzi, Farah F; Zibara, Kazem K; Bourgeais, Jerome J; Picou, Frederic F; Gallay, Nathalie N; Brossaud, Julie J; Dakik, Hassan H; Roux, Benjamin B; Hamard, Sophie S; Le Nail, Louis-Romee LR; Hleihel, Rita R; Foucault, Amelie A; Ravalet, Noemie N; Rouleux-Bonnin, Florence F; Gouilleux, Fabrice F; Mazurier, Frederic F; Bene, Marie C MC; Akl, Haidar H; Gyan, Emmanuel E; Domenech, Jorge J; El-Sabban, Marwan M; Herault, Olivier O
Publication Date: 2020-02

Variant appearance in text: TET2: 4044+1G>A
PubMed Link: 31649334
Variant Present in the following documents:
  • 41388_2019_1069_MOESM3_ESM.pdf
View BVdb publication page